General MedicationsORALGeneric
PROPULSID QUICKSOLV
CISAPRIDE MONOHYDRATE
Standard Dose
EQ 20MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview PROPULSID QUICKSOLV is listed in Drugs@FDA under application 020767 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient CISAPRIDE MONOHYDRATE Form and strength TABLET, ORALLY DISINTEGRATING;ORAL - EQ 20MG BASE Sponsor JANSSEN PHARMA Submission history Latest submission status date: 2000-03-06 00:00:00.
Structured Monograph
Clinical summary
Approval overview PROPULSID QUICKSOLV is listed in Drugs@FDA under application 020767 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CISAPRIDE MONOHYDRATE Form and strength TABLET, ORALLY DISINTEGRATING;ORAL - EQ 20MG BASE Sponsor JANSSEN PHARMA Submission history Latest submission status date: 2000-03-06 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.